Prot# CT-2011-01: Phase II Study to Evaluate the Safety, Tolerability and Efficacy of CT-011 Administered Intravenously to Patients with Metastatic Melanoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date11/9/117/31/14

    Funding

    • CureTech Ltd. (CT-2011-01)